AMGEN PRESENTS POSITIVE PHASE 3 DATA FOR UPLIZNA® (INEBILIZUMAB-CDON) IN GENERALIZED MYASTHENIA GRAVIS (GMG) AT AANEM 2024

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. INTC
2. SPCX
3. DSX
4. GNK
5. AWK
6. MDA
7. ACN
8. NTMFF
9. III
10. SAN

Go back to AMGEN PRESENTS POSITIVE PHASE 3 DATA FOR UPLIZNA® (INEBILIZUMAB-CDON) IN GENERALIZED MYASTHENIA GRAVIS (GMG) AT AANEM 2024
Amgen Inc (NASDAQ: AMGN) Delayed: 337.60 --0 (-0%)
Previous Close $337.60    52 Week High $176.85 
Open $337.60    52 Week Low $133.64 
Day High $337.60    P/E 50.84 
Day Low $337.60    EPS $6.64 
Volume 246